Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction

Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD. Related Content:

• Atorvastatin for Anthracycline-Associated Cardiac Dysfunction